Recombinant Proteins

India Mandates BIS Filing for Recombinant Proteins from July 1, 2026. Learn who is affected, key port risks, filing steps, and how exporters can avoid costly India shipment delays.

USP <1085> update adds an LC-MS HCP report rule for recombinant proteins in GMP export. Learn what the ≤1 ppm requirement means for compliance, release readiness, and global pharma supply.

USP <1085> tightens HCP reporting for recombinant proteins, setting a 10 ppm limit and LC-MS/MS validation. Learn what suppliers, GMP buyers, and regulatory teams must do before Dec 1, 2026.

USP <1085> tightens HCP limits for recombinant proteins to ≤10 ppm, requiring LC-MS/MS reports for export batches. Learn the compliance impact before October 2026.